X4 Pharmaceuticals, Inc. (GETTEX:48Q0) IPO
IPO
Went public as Arsanis, Inc. Priced at US$10.00 a share on Nov 15, 2017.
- Price
- US$10.00 a share
- Shares offered
- 4,000,000 shares of common stock
- Offering size
- US$40 million
- Underwriters' option
- Up to 600,000 more shares
- Underwriters
- Citigroup, Cowen, Piper Jaffray · In the order on the cover
- Shares delivered
- On or about Nov 20, 2017
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Aug 10, 2017 |
| Filed publicly | Oct 20, 2017 |
| Amended twice | Newest Nov 15, 2017 |
| Shares registered with an exchange | Nov 15, 2017 |
| Declared effective by the SEC | Nov 15, 2017 |
| Final prospectus, with the price | Nov 17, 2017 |
Filings
| Filing | Filed |
|---|---|
| 424B1 · Prospectus | Nov 17, 2017 |
| EFFECT · Notice that a registration is effective | Nov 15, 2017 |
| CERTNAS · Nasdaq's certificate of listing | Nov 15, 2017 |
| S-1/A · Registration statement, amended | Nov 15, 2017 |
| 8-A12B · Registration of shares for listing on an exchange | Nov 15, 2017 |
| CORRESP · Letter to the SEC | Nov 13, 2017 |
| CORRESP · Letter to the SEC | Nov 13, 2017 |
| S-1/A · Registration statement, amended | Nov 6, 2017 |
| CORRESP · Letter to the SEC | Oct 26, 2017 |
| CORRESP · Letter to the SEC | Oct 20, 2017 |
| S-1 · Registration statement | Oct 20, 2017 |
| UPLOAD · Letter from the SEC | Oct 4, 2017 |
| DRSLTR · Letter to the SEC with a draft | Sep 20, 2017 |
| DRS/A · Draft registration statement, amended | Sep 20, 2017 |
| UPLOAD · Letter from the SEC | Sep 6, 2017 |
| DRS · Draft registration statement | Aug 10, 2017 |
From the cover of the final prospectus (424B1) filed Nov 17, 2017